首页> 美国卫生研究院文献>British Journal of Cancer >Coexpression of invasive markers (uPA CD44) and multiple drug-resistance proteins (MDR1 MRP2) is correlated with epithelial ovarian cancer progression

【2h】

Coexpression of invasive markers (uPA CD44) and multiple drug-resistance proteins (MDR1 MRP2) is correlated with epithelial ovarian cancer progression

机译：侵袭性标志物（uPACD44）和多种耐药蛋白（MDR1MRP2）的共表达与上皮性卵巢癌的进展有关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Invasion and metastases of cancer cells and the development of resistance to anticancer therapies are the main causes of treatment failure and mortality in cancer patients.

机译：背景：癌细胞的侵袭和转移以及对抗癌疗法的耐药性的发展是癌症患者治疗失败和死亡的主要原因。

著录项

期刊名称 British Journal of Cancer
作者
H Chen; J Hao; L Wang; Y Li;
展开▼
作者单位

展开▼
年(卷),期 2009(101),3
年度 2009
页码 432–440
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
epithelial ovarian cancer uPA CD44 multiple drug-resistance proteins metastasis;

机译：上皮性卵巢癌;uPA;CD44;多种耐药蛋白;转移;

相似文献

外文文献
中文文献
专利

1. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression [J] . H Chen, J Hao, L Wang, British Journal of Cancer . 2009,第3期

机译：侵袭性标志物（uPA，CD44）和多种耐药蛋白（MDR1，MRP2）的共表达与上皮性卵巢癌的进展有关
2. High frequency of putative ovarian cancer stem cells with CD44/CK19 coexpression is associated with decreased progression-free intervals in patients with recurrent epithelial ovarian cancer [J] . LiuM., MorG., ChengH., Reproductive sciences . 2013,第5期

机译：CD44 / CK19共表达的卵巢癌干细胞频率高与复发性上皮性卵巢癌患者的无进展间隔时间减少有关
3. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer. [J] . Ping Liu, Yu-Lei Sun, Jie Du, International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2012,第4期

机译：CD105 / Ki67共表达与上皮性卵巢癌的肿瘤进展和不良预后相关。
4. Personalized versus Population Variability of Proteins in Chicken Plasma as a Model of Epithelial Ovarian Cancer Utilizing Multiple Reaction Monitoring [C] . Genna L. Andrews, James N. Petitte, David C. Muddiman, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：鸡等离子体中蛋白质的个性化与种群可变异，是利用多重反应监测的上皮卵巢癌模型
5. The role of KLF6 and KLF6-SV1 in the development and progression of epithelial ovarian cancer: Identification of a novel pro-survival protein that regulates apoptosis. [D] . DiFeo, Analisa. 2008

机译：KLF6和KLF6-SV1在上皮性卵巢癌的发展和进程中的作用：调节细胞凋亡的新型前生存蛋白的鉴定。
6. High Frequency of Putative Ovarian Cancer Stem Cells With CD44/CK19 Coexpression Is Associated With Decreased Progression-Free Intervals In Patients With Recurrent Epithelial Ovarian Cancer [O] . Ming Liu, Gil Mor, Huan Cheng, -1

机译：CD44 / CK19共表达的推定卵巢干细胞的高频率与复发性上皮性卵巢癌患者无进展间隔时间的减少相关
7. Coexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression [O] . Chen, H, Hao, J, Wang, L, 2009

机译：侵袭性标志物（uPA，CD44）和多种耐药蛋白（MDR1，MRP2）的共表达与上皮性卵巢癌的进展有关
8. Coexpression of the Follicle Stimulating Hormone Receptor and Stem Cell Markers: A Novel Approach to Target Ovarian Cancer Stem Cells. [R] . Schomberg, D. W. 2016

机译：卵泡刺激素受体和干细胞标志物的共表达：一种靶向卵巢癌干细胞的新方法。

Coexpression of invasive markers (uPA CD44) and multiple drug-resistance proteins (MDR1 MRP2) is correlated with epithelial ovarian cancer progression

摘要

著录项

相似文献

相关主题

期刊订阅